Corcept Therapeutics
CORT
#2099
Rank
NZ$15.45 B
Marketcap
NZ$146.69
Share price
2.60%
Change (1 day)
44.73%
Change (1 year)

Corcept Therapeutics (CORT) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$10.93 Million

According to Corcept Therapeutics 's latest financial reports the company's total debt is NZ$10.93 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Corcept Therapeutics - Total debt on balance sheet (from 2003 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$12.29 M5050.71%
2023-12-31NZ$0.23 M-86.74%
2022-12-31NZ$1.8 M133.78%
2021-12-31NZ$0.77 M-78.22%
2020-12-31NZ$3.53 M-31.2%
2019-12-31NZ$5.13 M
2018-12-31N/A
2016-12-31NZ$21.16 M-3.18%
2015-12-31NZ$21.86 M81.79%
2014-12-31NZ$12.02 M72.11%
2013-12-31NZ$6.98 M116.95%
2012-12-31NZ$3.22 M
2010-12-31N/A-100%
2009-12-31NZ$0 M-70.04%
2008-12-31NZ$0.02 M-27.17%
2007-12-31NZ$0.03 M-36.5%
2006-12-31NZ$0.05 M-24.54%
2005-12-31NZ$0.07 M
2003-12-31NZ$0.8 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$78.74 B 720,173.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$87.76 B 802,683.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$55.06 B 503,548.95%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$73.09 B 668,453.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$104.62 B 956,930.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$71.14 B 650,639.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.52 B 4,725.34%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
NZ$0.20 B 1,785.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$1.03 B 9,403.63%๐Ÿ‡บ๐Ÿ‡ธ USA